Results for
""Hirudin Therapy""[mesh_terms]

Coagulation inhibitor replacement during sepsis: useless?

E Faist, J N Hoffman

Critical care medicine 2000;28(9 Suppl):S74-6

Bivalirudin, a bivalent, thrombin specific anticoagulant as an alternative to heparin in interventional procedures as an alternative to heparin in interventional procedures.

D P Chew

Hamostaseologie 2002;22(3):60-6

Anticoagulation with recombinant hirudin and danaparoid sodium in pediatric patients.

Anton H Sutor, Barbara Zieger, Thomas Severin

Seminars in thrombosis and hemostasis 2003;28(5):447-54

Pharmacological strategies for inhibition of thrombin activity.

S Alban

Current pharmaceutical design 2008;14(12):1152-75

Anticoagulation in continuous renal replacement therapy.

O Vargas Hein, W J Kox, C Spies

Contributions to nephrology 2004;144():308-16

The use of bivalirudin in patients with renal impairment.

R Robson

The Journal of invasive cardiology 2001;12 Suppl F():33F-6

Beyond heparin and aspirin: new treatments for unstable angina and non-Q-wave myocardial infarction.

J I Weitz, S M Bates

Archives of internal medicine 2000;160(6):749-58

Reactivation of ischemic events in acute coronary syndromes: results from GUSTO-IIb. Gobal Use of Strategies To Open occluded arteries in acute coronary syndromes.

R M Califf, E J Topol, V Hasselblad, P W Armstrong, J Hirsh, D A Criger, A Betriu, C B Granger, M C Bahit, D Ardissino

Journal of the American College of Cardiology 2001;37(4):1001-7

Hirudin in heparin-induced thrombocytopenia.

Norbert Lubenow, Andreas Greinacher

Seminars in thrombosis and hemostasis 2003;28(5):431-8

Dabigatran: new drug. Continue to use heparin, a better-known option.

Prescrire international 2009;18(101):97-9

Anticoagulation: the present and future.

H Van Aken, C Bode, H Darius, C Diehm, A Encke, D C Gulba, S Haas, W Hacke, W Puhl, M Quante, H Riess, R Scharf, S Schellong, T Schrör, K L Schulte, U Tebbe

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2001;7(3):195-204